122 related articles for article (PubMed ID: 35202050)
21. Impact of HIV and Atiretroviral Therapy on Neurocognitive Outcomes Among School-Aged Children.
Brahmbhatt H; Boivin M; Ssempijja V; Kagaayi J; Kigozi G; Serwadda D; Violari A; Gray RH
J Acquir Immune Defic Syndr; 2017 May; 75(1):1-8. PubMed ID: 28169874
[TBL] [Abstract][Full Text] [Related]
22. Neurodevelopment in children born to HIV-infected mothers by infection and treatment status.
Le Doaré K; Bland R; Newell ML
Pediatrics; 2012 Nov; 130(5):e1326-44. PubMed ID: 23118140
[TBL] [Abstract][Full Text] [Related]
23. Pulse wave velocity in early-treated children living with perinatal HIV infection is similar to uninfected children.
Davies C; Vaida F; Otwombe K; Cotton MF; Browne SH; Innes S
AIDS; 2023 Jun; 37(7):1115-1123. PubMed ID: 36928069
[TBL] [Abstract][Full Text] [Related]
24. Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV.
Kerr SJ; Puthanakit T; Vibol U; Aurpibul L; Vonthanak S; Kosalaraksa P; Kanjanavanit S; Hansudewechakul R; Wongsawat J; Luesomboon W; Ratanadilok K; Prasitsuebsai W; Pruksakaew K; van der Lugt J; Paul R; Ananworanich J; Valcour V;
AIDS Care; 2014; 26(11):1327-35. PubMed ID: 24878112
[TBL] [Abstract][Full Text] [Related]
25. Growth patterns of uninfected children born to women living with perinatally versus nonperinatally acquired HIV.
Yu W; Jacobson DL; Williams PL; Patel K; Geffner ME; Van Dyke RB; Kacanek D; DiMeglio LA; Jao J;
AIDS; 2022 Mar; 36(4):593-603. PubMed ID: 34860195
[TBL] [Abstract][Full Text] [Related]
26. In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children.
Yao TJ; Malee K; Zhang J; Smith R; Redmond S; Rice ML; Frederick T; Torre P; Mellins CA; Hoffman HJ; Williams PL
AIDS Patient Care STDS; 2023 Mar; 37(3):119-130. PubMed ID: 36827595
[TBL] [Abstract][Full Text] [Related]
27. Neurodevelopment among children exposed to HIV and uninfected in sub-Saharan Africa.
Bulterys MA; Njuguna I; Mahy M; Gulaid LA; Powis KM; Wedderburn CJ; John-Stewart G
J Int AIDS Soc; 2023 Oct; 26 Suppl 4(Suppl 4):e26159. PubMed ID: 37909232
[TBL] [Abstract][Full Text] [Related]
28. Decreased growth among antiretroviral drug and HIV-exposed uninfected versus unexposed children in Malawi and Uganda.
Aizire J; Sikorskii A; Ogwang LW; Kawalazira R; Mutebe A; Familiar-Lopez I; Mallewa M; Taha T; Boivin MJ; Fowler MG;
AIDS; 2020 Feb; 34(2):215-225. PubMed ID: 31634154
[TBL] [Abstract][Full Text] [Related]
29. A Neurometabolic Pattern of Elevated Myo-Inositol in Children Who Are HIV-Exposed and Uninfected: A South African Birth Cohort Study.
Bertran-Cobo C; Wedderburn CJ; Robertson FC; Subramoney S; Narr KL; Joshi SH; Roos A; Rehman AM; Hoffman N; Zar HJ; Stein DJ; Donald KA
Front Immunol; 2022; 13():800273. PubMed ID: 35419007
[TBL] [Abstract][Full Text] [Related]
30. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
Williams PL; Yildirim C; Chadwick EG; Van Dyke RB; Smith R; Correia KF; DiPerna A; Seage GR; Hazra R; Crowell CS;
Lancet HIV; 2020 Jan; 7(1):e49-e58. PubMed ID: 31740351
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth.
Guerra V; Leister EC; Williams PL; Starc TJ; Lipshultz SE; Wilkinson JD; Van Dyke RB; Hazra R; Colan SD
AIDS Res Hum Retroviruses; 2016 Jul; 32(7):621-7. PubMed ID: 26794032
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for stunting in children who are HIV-exposed and uninfected after Option B+ implementation in Malawi.
Toledo G; Landes M; van Lettow M; Tippett Barr BA; Bailey H; Crichton S; Msungama W; Thorne C
Matern Child Nutr; 2023 Jan; 19(1):e13451. PubMed ID: 36349962
[TBL] [Abstract][Full Text] [Related]
33. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
[TBL] [Abstract][Full Text] [Related]
34. Neurodevelopmental outcomes in young children born to HIV-positive mothers in rural Yunnan, China.
Wu J; Li J; Li Y; Loo KK; Yang H; Wang Q; Duan R; Xiao X; Song X; Yang S; Sun L
Pediatr Int; 2018 Jul; 60(7):618-625. PubMed ID: 29663621
[TBL] [Abstract][Full Text] [Related]
35. Maternal depression and infant social withdrawal as predictors of behaviour and development in vertically HIV-infected children at 3.5 years.
Nöthling J; Laughton B; Seedat S
Paediatr Int Child Health; 2021 Nov; 41(4):268-277. PubMed ID: 35235497
[TBL] [Abstract][Full Text] [Related]
36.
Williams SR; Robertson FC; Wedderburn CJ; Ringshaw JE; Bradford L; Nyakonda CN; Hoffman N; Joshi SH; Zar HJ; Stein DJ; Donald KA
Front Neurosci; 2023; 17():1251575. PubMed ID: 37901429
[TBL] [Abstract][Full Text] [Related]
37. Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial.
Boivin MJ; Barlow-Mosha L; Chernoff MC; Laughton B; Zimmer B; Joyce C; Bwakura-Dangarembizi M; Ratswana M; Abrahams N; Fairlie L; Gous H; Kamthunzi P; McCarthy K; Familiar-Lopez I; Jean-Phillippe P; Coetzee J; Violari A; Cotton MF; Palumbo PE;
AIDS; 2018 Jan; 32(2):189-204. PubMed ID: 29112069
[TBL] [Abstract][Full Text] [Related]
38. The role of internalised HIV stigma in disclosure of maternal HIV serostatus to children perinatally HIV-exposed but uninfected: a prospective study in the United States.
Davtyan M; Kacanek D; Lee J; Berman C; Chadwick EG; Smith R; Salomon L; Frederick T;
J Int AIDS Soc; 2023 Oct; 26 Suppl 4(Suppl 4):e26167. PubMed ID: 37909234
[TBL] [Abstract][Full Text] [Related]
39. In utero and peripartum antiretroviral exposure as predictor of cognition in 6- to 10-year-old HIV-exposed Ugandan children - a prospective cohort study.
Ezeamama AE; Zalwango SK; Sikorskii A; Tuke R; Musoke PM; Giordani B; Boivin MJ
HIV Med; 2021 Aug; 22(7):592-604. PubMed ID: 33860626
[TBL] [Abstract][Full Text] [Related]
40. No Difference in Growth Outcomes up to 24 Months of Age by Duration of Exposure to Maternal Antiretroviral Therapy Among Children Who Are HIV-Exposed and Uninfected in Malawi.
Toledo G; Landes M; van Lettow M; Tippett Barr BA; Bailey H; Thorne C; Crichton S
Front Pediatr; 2022; 10():882468. PubMed ID: 35795331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
